Todd; Richard Simon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Todd; Richard Simon.The latest application filed is for "solid forms of a plasma kallikrein inhibitor and salts thereof".

Company Profile

1.14.12

Todd; Richard Simon - Wiltshire GB
TODD; Richard Simon - Salisbury GB
Todd; Richard Simon - Winnersh GB
Todd; Richard Simon - Wokingham GB
Todd; Richard Simon - Harlow GB
Todd; Richard Simon - Berkshire GB
TODD; Richard Simon - Burnham Slough GB
Todd; Richard Simon - Oxford GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosage forms comprising a plasma kallikrein inhibitor Grant 11,234,939 - Collett , et al. February 1, 2	2022-02-01
Solid Forms Of A Plasma Kallikrein Inhibitor And Salts Thereof App 20210171496 - CROWE; David Malcolm ; et al.	2021-06-10
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20210115054 - Bamford; Samantha Jane ; et al.	2021-04-22
Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists Grant 10,875,868 - Bamford , et al. December 29, 2	2020-12-29
Dosage Forms Comprising A Plasma Kallikrein Inhibitor App 20200345647 - COLLETT; John Herman ; et al.	2020-11-05
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20200172547 - Bamford; Samantha Jane ; et al.	2020-06-04
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 10,538,526 - Bamford , et al. Ja	2020-01-21
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20190031668 - Bamford; Samantha Jane ; et al.	2019-01-31
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 10,106,547 - Bamford , et al. October 23, 2	2018-10-23
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20170342081 - Bamford; Samantha Jane ; et al.	2017-11-30
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 9,765,080 - Bamford , et al. September 19, 2	2017-09-19
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20170088552 - Bamford; Samantha Jane ; et al.	2017-03-30
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 9,376,443 - Bamford , et al. June 28, 2	2016-06-28
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20150291602 - Bamford; Samantha Jane ; et al.	2015-10-15
Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 8,987,279 - Bamford , et al. March 24, 2	2015-03-24
Triazolo[4, 5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20130245044 - Bamford; Samantha Jane ; et al.	2013-09-19
Triazolo[4,5-D]pyramidine derivatives and their use as purine receptor antagonists Grant 8,450,328 - Bamford , et al. May 28, 2	2013-05-28
Triazolo[4,5-d]pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20110172252 - Bamford; Samantha Jane ; et al.	2011-07-14
Pyrimidine compounds as purine receptor antagonist Grant 7,875,600 - Gillespie , et al. January 25, 2	2011-01-25
Substituted bis aryl and heteroaryl compounds as selective 5HT.sub.2A antagonists Grant 7,625,889 - Eastwood , et al. December 1, 2	2009-12-01
Pyrimidine Compounds as Purine Receptor Antagonist App 20070281936 - Gillespie; Roger John ; et al.	2007-12-06
Substituted Bis Aryl And Heteroaryl Compounds As Selective 5ht2a Antagonists App 20070265309 - EASTWOOD; Paul Robert ; et al.	2007-11-15
Antimicrobial agents Grant 6,716,878 - Todd , et al. April 6, 2	2004-04-06
Metalloproteinase inhibitors Grant 6,358,987 - Beckett , et al. March 19, 2	2002-03-19
Metalloproteinase inhibitors Grant 6,271,262 - Beckett , et al. August 7, 2	2001-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.